BIOCRYST PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Biocryst Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 207M shares, a 9.12% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 207M +17.3M +9.12% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 207M +17.1M +9.04% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 206M +17.5M +9.25% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 206M +17.9M +9.51% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 190M +3.39M +1.82% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 189M +3.62M +1.95% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 189M +3.31M +1.78% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 188M +3.56M +1.93% Dec 31, 2022 10-K 2024-02-27
Q3 2022 186M +6.62M +3.68% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 186M +7.15M +4% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 186M +7.9M +4.45% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 184M +7.47M +4.22% Dec 31, 2021 10-K 2023-02-27
Q3 2021 180M +3.23M +1.83% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 179M +2.3M +1.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 178M +23.5M +15.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 177M +22.8M +14.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 177M +66.1M +59.9% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 176M +66.1M +59.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 154M +43.9M +39.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 154M +44M +40% Dec 31, 2019 10-K 2021-03-01
Q3 2019 110M +813K +0.74% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 110M +11.4M +11.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 110M +11.6M +11.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 110M +11.7M +11.8% Dec 31, 2018 10-K 2020-03-13
Q3 2018 110M +11.2M +11.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 98.9M +18.5M +23% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 98.7M +18.3M +22.8% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 98.4M +24.6M +33.4% Dec 31, 2017 10-K 2019-03-14
Q3 2017 98.4M +24.6M +33.4% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 80.4M +6.73M +9.13% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 80.4M +6.69M +9.08% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 73.8M +427K +0.58% Dec 31, 2016 10-K 2018-03-12
Q3 2016 73.8M +421K +0.57% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 73.7M +533K +0.73% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 73.7M +1.22M +1.68% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 73.4M +1.4M +1.95% Dec 31, 2015 10-K 2017-02-27
Q3 2015 73.3M +1.48M +2.05% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 73.2M +1.45M +2.02% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 72.5M +12.4M +20.7% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 72M +12.9M +21.8% Dec 31, 2014 10-K 2016-02-26
Q3 2014 71.9M +12.8M +21.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 71.7M +17.5M +32.3% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 60.1M +8.66M +16.8% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 59.1M +8.2M +16.1% Dec 31, 2013 10-K 2015-03-02
Q3 2013 59.1M +8.21M +16.1% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 54.2M +4.07M +8.12% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 51.4M +2.25M +4.58% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 50.9M +5.23M +11.5% Dec 31, 2012 10-K 2014-03-10
Q3 2012 50.9M +50.8M Sep 30, 2012 10-Q 2012-11-08
Q2 2012 50.1M +50.1M Jun 30, 2012 10-Q 2012-08-08
Q1 2012 49.2M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 45.7M +703K +1.56% Dec 31, 2011 10-K 2013-03-11
Q3 2011 45.2K* Sep 30, 2011 10-Q 2011-11-03
Q2 2011 45.2K* Jun 30, 2011 10-Q 2011-08-04
Q4 2010 45M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.